Inequalities in human papillomavirus (HPV)-associated cancers: Implications for the success of HPV vaccination

Journal of the National Cancer Institute

Volumn 105, Issue 3, 2013, Pages 158-161

  Brisson, Marc ^a,b,c   Drolet, Mélanie ^a,b   Malagón, Talía ^a,b  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ANUS CANCER; CANCER INCIDENCE; CANCER MORTALITY; DISEASE ASSOCIATION; ETHNIC AND RACIAL GROUPS; GYNECOLOGIC CANCER; HERD IMMUNITY; HUMAN; MORTALITY; NEOPLASM; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; TREND STUDY; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION;

ALPHAPAPILLOMAVIRUS; COST OF ILLNESS; FEMALE; HUMANS; MALE; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES;

EID: 84873591289     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs638     Document Type: Review

References (45)

1. Jemal A, Simard E, Dorell C, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in HPVassociated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2012;105(3):xxx-xxx.
2. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control. 2005;16(1):63-70.
3. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105(5):687-691.
4. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer. 2004;100(5):1035-1044.
5. Scarinci IC, Garcia FA, Kobetz E, et al. Cervical cancer prevention: new tools and old barriers. Cancer. 2010;116(11):2531-2542.
6. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675-683.
7. Risendal B, DeZapien J, Fowler B, et al. Pap smear screening among urban Southwestern American Indian women. Prev Med. 1999;29(6 Pt 1):510-518.
8. Peto J, Gilham C, Deacon J, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer. 2004;91(5):942-953.
9. Yabroff KR, Lawrence WF, King JC, et al. Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment? J Rural Health. 2005;21(2): 149-157.
10. Owusu GA, Eve SB, Cready CM, et al. Race and ethnic disparities in cervical cancer screening in a safety-net system. Matern Child Health J. 2005;9(3):285-295.
11. Blackwell DL, Martinez ME, Gentleman JF. Women's compliance with public health guidelines for mammograms and Pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health. Womens Health Issues. 2008;18(2):85-99.
12. Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372(9635):337-340.
13. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis. 1999;26(5):250-261.
14. Watts CH, May RM. The influence of concurrent partnerships on the dynamics of HIV/AIDS. Math Biosci. 1992;108(1):89-104.
15. Kraut-Becher JR, Aral SO. Gap length: an important factor in sexually transmitted disease transmission. Sex Transm Dis. 2003;30(3):221-225.
16. Boily MC, Lowndes CM, Gregson S. Population-level risk factors for HIV transmission and "the 4 Cities Study": temporal dynamics and the significance of sexual mixing patterns. AIDS. 2002;16(15):2101-2102.
17. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. New York: Oxford University Press; 1991.
18. Morris M, Kurth AE, Hamilton DT, et al. Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health. 2009;99(6):1023-1031.
19. Chen MI, Ghani AC, Edmunds J. Mind the gap: the role of time between sex with two consecutive partners on the transmission dynamics of gonorrhea. Sex Transm Dis. 2008;35(5):435-444.
20. Chen MI, Ghani AC, Edmunds WJ. A metapopulation modelling framework for gonorrhoea and other sexually transmitted infections in heterosexual populations. J R Soc Interface. 2009;6(38):775-791.
21. Kretzschmar M, Dietz K. The effect of pair formation and variable infectivity on the spread of an infection without recovery. Math Biosci. 1998;148(1):83-113.
22. Foxman B, Newman M, Percha B, et al. Measures of sexual partnerships: lengths, gaps, overlaps, and sexually transmitted infection. Sex Transm Dis. 2006;33(4):209-214.
23. Langille DB, Asbridge M, Flowerdew G, et al. Associations of sexual risktaking with having intercourse before 15 years in adolescent females in Cape Breton, Nova Scotia, Canada. Sex Health. 2010;7(2):199-204.
24. Greenberg J, Magder L, Aral S. Age at first coitus. A marker for risky sexual behavior in women. Sex Transm Dis. 1992;19(6):331-334.
25. Sandfort TG, Orr M, Hirsch JS, et al. Long-term health correlates of timing of sexual debut: results from a national US study. Am J Public Health. 2008;98(1):155-161.
26. Ma Q, Ono-Kihara M, Cong L, et al. Early initiation of sexual activity: a risk factor for sexually transmitted diseases, HIV infection, and unwanted pregnancy among university students in China. BMC Public Health. 2009;9(111).
27. International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1060-1069.
28. Centers for Disease Control and Prevention. Youth Risk Behavior Surveillance System (YRBSS). http://www.cdc.gov/healthyyouth/yrbs/index.htm. Accessed December 18, 2012.
29. Santelli JS, Lowry R, Brener ND, et al. The association of sexual behaviors with socioeconomic status, family structure, and race/ethnicity among US adolescents. Am J Public Health. 2000;90(10):1582-1588.
30. Biello KB, Niccolai L, Kershaw TS, et al. Residential racial segregation and racial differences in sexual behaviours: an 11-year longitudinal study of sexual risk of adolescents transitioning to adulthood. J Epidemiol Community Health. 2013;67(1):28-34.
31. Drolet M, Brisson M. Sociodemographic inequalities in the main risk factors for HPV-related diseases. Paper presented at the 27th International Papillomavirus Conference; September 2011; Berlin, Germany.
32. Hallfors DD, Iritani BJ, Miller WC, et al. Sexual and drug behavior patterns and HIV and STD racial disparities: the need for new directions. Am J Public Health 2007;97(1):125-132.
33. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis. 2011;204(4):566-573.
34. Menzies R, McIntyre P. Vaccine preventable diseases and vaccination policy for indigenous populations. Epidemiol Rev. 2006;28:71-80.
35. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA. 2004;291(18):2197-2203.
36. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ. 1999;319(7223):1462-1467.
37. Brisson M, Edmunds WJ. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making. 2003;23(1):76-82.
38. Soto K, Petit S, Hadler JL. Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ethnicity in Connecticut, 1998-2008. Public Health Rep. 2011;126(Suppl 3):81-88.
39. Fairley C, Ali H, Guy R, et al. Genital warts in young Australian women: going, going. Paper presented at the 28th International Papillomavirus Conference; December 2012; San Juan, Puerto Rico.
40. Read TR, Hocking JS, Chen MY, et al. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011;87(7):544-547.
41. Brisson M. Potential impact of HPV vaccination on health disparities. Paper presented at EUROGIN; May 2011; Lisbon, Portugal.
42. ACIP. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705-1708.
43. Brisson M, Van de Velde N, Franco EL, et al. Incremental impact of adding boys to current HPV vaccination programmes: role of herd immunity. J Infect Dis. 2011;204(3):372-376.
44. Castle PE, Zhao FH. Population effectiveness, not efficacy, should decide who gets vaccinated against human papillomavirus via publicly funded programs. J Infect Dis. 2011;204(3):335-337.
45. Bogaards JA, Kretzschmar M, Xiridou M, et al. Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med. 2011;8(12):e1001147.